Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Nanopareil LLC currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner and 1 distinct art unit, which defines the current prosecution footprint for the organization's filings.
The busiest examiner for this portfolio is NGUYEN, NAM P, who is responsible for 1 pending office action. This individual workload accounts for the total volume of the organization's current pending actions at the office. Having 1 distinct examiner indicates that the legal strategy is currently focused on a specific niche within the Biotechnology & Pharmaceuticals sector.
Furthermore, the presence of 1 distinct art unit implies that the technical subject matter of the pending application falls under a specific administrative division. Practitioners should note that with 1 pending office action, the overall prosecution velocity for the portfolio is tied directly to the response timeline of NGUYEN, NAM P.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANDERSON, LEE E | 1 | 45.2% | +45.2% |
| NGUYEN, NAM P | 1 | 54.8% | +48.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18398622 | HYBRID FELTS OF ELECTROSPUN NANOFIBERS | SANDERSON, LEE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17937251 | SURFACE FUNCTIONALIZED AFFINITY MEMBRANES | NGUYEN, NAM P | 30d overdue |
| 18398622 | HYBRID FELTS OF ELECTROSPUN NANOFIBERS | SANDERSON, LEE E | — |
| Art Unit | Apps |
|---|---|
| 3991 | 1 |
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18398622 | HYBRID FELTS OF ELECTROSPUN NANOFIBERS | SANDERSON, LEE E | 3991 | §103§112 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 17937251 | SURFACE FUNCTIONALIZED AFFINITY MEMBRANES | NGUYEN, NAM P | 1678 | §103DP | Final Rejection | 30d overdue | Pending | Sep 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanopareil LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Lee E Sanderson has the most, with 1 of Nanopareil LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
